Formas cristalinas de un inhibidor del Factor Xa

Una forma cristalina del maleato de betrixabán que tiene: i) un patrón de difracción de rayos X en polvo parecido al patrón de difracción de rayos X en polvo mostrado en la Figura 2 o 3; o iv) una estructura de celda unitaria con los siguientes parámetros de la celda a 100 K: a >= 8,284 Å, b >...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MARGELEFSKY, Eric, CAPODANNO, Vincent, WENSLOW, Robert, MAHER, Timothy, ARROYO, Itzia Zoraida, CORCORAN, Liam, McNEVIN, Michael, BALL, Richard, PANDEY, Anjali
Format: Patent
Sprache:spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MARGELEFSKY, Eric
CAPODANNO, Vincent
WENSLOW, Robert
MAHER, Timothy
ARROYO, Itzia Zoraida
CORCORAN, Liam
McNEVIN, Michael
BALL, Richard
PANDEY, Anjali
description Una forma cristalina del maleato de betrixabán que tiene: i) un patrón de difracción de rayos X en polvo parecido al patrón de difracción de rayos X en polvo mostrado en la Figura 2 o 3; o iv) una estructura de celda unitaria con los siguientes parámetros de la celda a 100 K: a >= 8,284 Å, b >= 18,082 Å, c >= 18,681 Å, α >= 71,22 º, ß >= 86,76 º, γ >= 89,69 º, y V >= 2645 A3; o v) una estructura de celda unitaria con los siguientes parámetros de la celda a 273 K: a >= 8,419 Å, b >= 18,113 Å, c >= 18,73 Å, α >= 71,14 º, ß >= 86,71 º, γ >= 89,31 º, y V >= 2699 A3. Provided herein are crystalline forms of a maleate salt of betrixaban, compositions and methods of preparation or use thereof.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2603084TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2603084TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2603084TT33</originalsourceid><addsrcrecordid>eNrjZDBwyy_KTSxWSC7KLC5JzMnMA7JTUhVK8xQy8zIykzJT8ouA_BwFt8TkEiAzIpGHgTUtMac4lRdKczMourmGOHvophbkx6cWFyQmp-allsS7BhuZGRgbWJiEhBgbE6MGADAkKx0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Formas cristalinas de un inhibidor del Factor Xa</title><source>esp@cenet</source><creator>MARGELEFSKY, Eric ; CAPODANNO, Vincent ; WENSLOW, Robert ; MAHER, Timothy ; ARROYO, Itzia Zoraida ; CORCORAN, Liam ; McNEVIN, Michael ; BALL, Richard ; PANDEY, Anjali</creator><creatorcontrib>MARGELEFSKY, Eric ; CAPODANNO, Vincent ; WENSLOW, Robert ; MAHER, Timothy ; ARROYO, Itzia Zoraida ; CORCORAN, Liam ; McNEVIN, Michael ; BALL, Richard ; PANDEY, Anjali</creatorcontrib><description>Una forma cristalina del maleato de betrixabán que tiene: i) un patrón de difracción de rayos X en polvo parecido al patrón de difracción de rayos X en polvo mostrado en la Figura 2 o 3; o iv) una estructura de celda unitaria con los siguientes parámetros de la celda a 100 K: a &gt;= 8,284 Å, b &gt;= 18,082 Å, c &gt;= 18,681 Å, α &gt;= 71,22 º, ß &gt;= 86,76 º, γ &gt;= 89,69 º, y V &gt;= 2645 A3; o v) una estructura de celda unitaria con los siguientes parámetros de la celda a 273 K: a &gt;= 8,419 Å, b &gt;= 18,113 Å, c &gt;= 18,73 Å, α &gt;= 71,14 º, ß &gt;= 86,71 º, γ &gt;= 89,31 º, y V &gt;= 2699 A3. Provided herein are crystalline forms of a maleate salt of betrixaban, compositions and methods of preparation or use thereof.</description><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170223&amp;DB=EPODOC&amp;CC=ES&amp;NR=2603084T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170223&amp;DB=EPODOC&amp;CC=ES&amp;NR=2603084T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MARGELEFSKY, Eric</creatorcontrib><creatorcontrib>CAPODANNO, Vincent</creatorcontrib><creatorcontrib>WENSLOW, Robert</creatorcontrib><creatorcontrib>MAHER, Timothy</creatorcontrib><creatorcontrib>ARROYO, Itzia Zoraida</creatorcontrib><creatorcontrib>CORCORAN, Liam</creatorcontrib><creatorcontrib>McNEVIN, Michael</creatorcontrib><creatorcontrib>BALL, Richard</creatorcontrib><creatorcontrib>PANDEY, Anjali</creatorcontrib><title>Formas cristalinas de un inhibidor del Factor Xa</title><description>Una forma cristalina del maleato de betrixabán que tiene: i) un patrón de difracción de rayos X en polvo parecido al patrón de difracción de rayos X en polvo mostrado en la Figura 2 o 3; o iv) una estructura de celda unitaria con los siguientes parámetros de la celda a 100 K: a &gt;= 8,284 Å, b &gt;= 18,082 Å, c &gt;= 18,681 Å, α &gt;= 71,22 º, ß &gt;= 86,76 º, γ &gt;= 89,69 º, y V &gt;= 2645 A3; o v) una estructura de celda unitaria con los siguientes parámetros de la celda a 273 K: a &gt;= 8,419 Å, b &gt;= 18,113 Å, c &gt;= 18,73 Å, α &gt;= 71,14 º, ß &gt;= 86,71 º, γ &gt;= 89,31 º, y V &gt;= 2699 A3. Provided herein are crystalline forms of a maleate salt of betrixaban, compositions and methods of preparation or use thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBwyy_KTSxWSC7KLC5JzMnMA7JTUhVK8xQy8zIykzJT8ouA_BwFt8TkEiAzIpGHgTUtMac4lRdKczMourmGOHvophbkx6cWFyQmp-allsS7BhuZGRgbWJiEhBgbE6MGADAkKx0</recordid><startdate>20170223</startdate><enddate>20170223</enddate><creator>MARGELEFSKY, Eric</creator><creator>CAPODANNO, Vincent</creator><creator>WENSLOW, Robert</creator><creator>MAHER, Timothy</creator><creator>ARROYO, Itzia Zoraida</creator><creator>CORCORAN, Liam</creator><creator>McNEVIN, Michael</creator><creator>BALL, Richard</creator><creator>PANDEY, Anjali</creator><scope>EVB</scope></search><sort><creationdate>20170223</creationdate><title>Formas cristalinas de un inhibidor del Factor Xa</title><author>MARGELEFSKY, Eric ; CAPODANNO, Vincent ; WENSLOW, Robert ; MAHER, Timothy ; ARROYO, Itzia Zoraida ; CORCORAN, Liam ; McNEVIN, Michael ; BALL, Richard ; PANDEY, Anjali</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2603084TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MARGELEFSKY, Eric</creatorcontrib><creatorcontrib>CAPODANNO, Vincent</creatorcontrib><creatorcontrib>WENSLOW, Robert</creatorcontrib><creatorcontrib>MAHER, Timothy</creatorcontrib><creatorcontrib>ARROYO, Itzia Zoraida</creatorcontrib><creatorcontrib>CORCORAN, Liam</creatorcontrib><creatorcontrib>McNEVIN, Michael</creatorcontrib><creatorcontrib>BALL, Richard</creatorcontrib><creatorcontrib>PANDEY, Anjali</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MARGELEFSKY, Eric</au><au>CAPODANNO, Vincent</au><au>WENSLOW, Robert</au><au>MAHER, Timothy</au><au>ARROYO, Itzia Zoraida</au><au>CORCORAN, Liam</au><au>McNEVIN, Michael</au><au>BALL, Richard</au><au>PANDEY, Anjali</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Formas cristalinas de un inhibidor del Factor Xa</title><date>2017-02-23</date><risdate>2017</risdate><abstract>Una forma cristalina del maleato de betrixabán que tiene: i) un patrón de difracción de rayos X en polvo parecido al patrón de difracción de rayos X en polvo mostrado en la Figura 2 o 3; o iv) una estructura de celda unitaria con los siguientes parámetros de la celda a 100 K: a &gt;= 8,284 Å, b &gt;= 18,082 Å, c &gt;= 18,681 Å, α &gt;= 71,22 º, ß &gt;= 86,76 º, γ &gt;= 89,69 º, y V &gt;= 2645 A3; o v) una estructura de celda unitaria con los siguientes parámetros de la celda a 273 K: a &gt;= 8,419 Å, b &gt;= 18,113 Å, c &gt;= 18,73 Å, α &gt;= 71,14 º, ß &gt;= 86,71 º, γ &gt;= 89,31 º, y V &gt;= 2699 A3. Provided herein are crystalline forms of a maleate salt of betrixaban, compositions and methods of preparation or use thereof.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language spa
recordid cdi_epo_espacenet_ES2603084TT3
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Formas cristalinas de un inhibidor del Factor Xa
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T20%3A11%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MARGELEFSKY,%20Eric&rft.date=2017-02-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2603084TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true